1 School of Public Health (Dr Boodram and Ms Kaufmann) and Cancer Center (Dr Hamlish), University of Illinois at Chicago; Department of Internal Medicine, University of Michigan, Ann Arbor and Sarcoma Alliance for Research Through Collaboration, Ann Arbor, Michigan (Dr Peregrine Antalis); University of Chicago Medicine, Chicago, Illinois (Drs Aronsohn and Johnson and Ms Rodriguez); Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania (Ms Kim); Caring Ambassadors Program, Inc, Chicago, Illinois (Ms Wolf); and Centers for Disease Control and Prevention, Atlanta, Georgia (Dr Millman)
An estimated 4.1 million people in the United States are infected with hepatitis C virus (HCV). In 2014, the Hepatitis CCommunity Alliance to Test and Treat (HepCCATT) collaborative was formed to address hepatitis C in Chicago. From 2014 to 2017, the HepCCATT Case Management Program case managed 181 HCV-infected people and performed on-site capacity building at a 6-site community health center (CHC) that produced codified protocols, which were translated into a telehealth program to build capacity within CHCs to deliver hepatitis C care. HepCCATT's innovative approach to addressing multilevel barriers is a potential model for increasing access to hepatitis C care and treatment.